Literature DB >> 22415539

Adipose tissue as regulator of vascular tone.

Charlotte Boydens1, Nele Maenhaut, Bart Pauwels, Kelly Decaluwé, Johan Van de Voorde.   

Abstract

Adipokines secreted by visceral, subcutaneous, and perivascular adipocytes are involved in the regulation of vascular tone by acting as circulatory hormones (leptin, adiponectin, omentin, visfatin, angiotensin II, resistin, tumor necrosis factor-α, interleukin-6, apelin) and/or via local paracrine factors (perivascular adipocyte-derived relaxing and contractile factors). Vascular tone regulation by adipokines is compromised in obesitas and obesity-related disorders. Hypoxia created in growing adipose tissue dysregulates synthesis of vasoactive adipokines in favor of harmful proinflammatory adipokines, while the levels of the cardioprotective adipokines adiponectin and omentin decrease. Considering the potential of the role of adipokines in obesity-related vascular diseases, strategies to counter these diseases by targeting the adipokines are discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22415539     DOI: 10.1007/s11906-012-0259-6

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  100 in total

Review 1.  Adipose tissue: the new endocrine organ? A review article.

Authors:  Susan E Wozniak; Laura L Gee; Mitchell S Wachtel; Eldo E Frezza
Journal:  Dig Dis Sci       Date:  2008-12-04       Impact factor: 3.199

2.  Angiotensin II hypertension is attenuated in interleukin-6 knockout mice.

Authors:  Dexter L Lee; Lashon C Sturgis; Hicham Labazi; James B Osborne; Cassandra Fleming; Jennifer S Pollock; Marlina Manhiani; John D Imig; Michael W Brands
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-11-11       Impact factor: 4.733

3.  Adiponectin in essential hypertension.

Authors:  Francesca Mallamaci; Carmine Zoccali; Fortunata Cuzzola; Giovanni Tripepi; Sebastiano Cutrupi; Saverio Parlongo; Sachiyo Tanaka; Noriyuki Ouchi; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa
Journal:  J Nephrol       Date:  2002 Sep-Oct       Impact factor: 3.902

4.  Hypoxia enhances the relaxing influence of perivascular adipose tissue in isolated mice aorta.

Authors:  Nele Maenhaut; Charlotte Boydens; Johan Van de Voorde
Journal:  Eur J Pharmacol       Date:  2010-06-08       Impact factor: 4.432

5.  Adiponectin replenishment ameliorates obesity-related hypertension.

Authors:  Koji Ohashi; Shinji Kihara; Noriyuki Ouchi; Masahiro Kumada; Koichi Fujita; Aki Hiuge; Toshiyuki Hibuse; Miwa Ryo; Hitoshi Nishizawa; Norikazu Maeda; Kazuhisa Maeda; Rei Shibata; Kenneth Walsh; Tohru Funahashi; Iichiro Shimomura
Journal:  Hypertension       Date:  2006-05-01       Impact factor: 10.190

6.  Leptin, not adiponectin, predicts hypertension in the Copenhagen City Heart Study.

Authors:  Camilla Asferg; Rasmus Møgelvang; Allan Flyvbjerg; Jan Frystyk; Jan S Jensen; Jacob L Marott; Merete Appleyard; Gorm B Jensen; Jørgen Jeppesen
Journal:  Am J Hypertens       Date:  2009-12-17       Impact factor: 2.689

Review 7.  Adipokines and blood pressure control.

Authors:  Frederique Yiannikouris; Manisha Gupte; Kelly Putnam; Lisa Cassis
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-03       Impact factor: 2.894

8.  Leptin-induced endothelial dysfunction in obesity.

Authors:  Mykhaylo Korda; Ruslan Kubant; Stephen Patton; Tadeusz Malinski
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-08-08       Impact factor: 4.733

Review 9.  Adipokines: inflammation and the pleiotropic role of white adipose tissue.

Authors:  Paul Trayhurn; I Stuart Wood
Journal:  Br J Nutr       Date:  2004-09       Impact factor: 3.718

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  11 in total

1.  Lean and Obese Coronary Perivascular Adipose Tissue Impairs Vasodilation via Differential Inhibition of Vascular Smooth Muscle K+ Channels.

Authors:  Jillian N Noblet; Meredith K Owen; Adam G Goodwill; Daniel J Sassoon; Johnathan D Tune
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-02       Impact factor: 8.311

2.  The influence of sodium- and calcium-regulatory hormone interventions on adipocytokines in obesity and diabetes.

Authors:  Anand Vaidya; Patricia C Underwood; Justin P Annes; Bei Sun; Gordon H Williams; John P Forman; Jonathan S Williams
Journal:  Metabolism       Date:  2012-11-09       Impact factor: 8.694

3.  Implication of circulating omentin-1 level on the arterial stiffening in type 2 diabetes mellitus.

Authors:  Hye Jin Yoo; Soon Young Hwang; Ho Cheol Hong; Hae Yoon Choi; Sae Jeong Yang; Kwan Woo Lee; Moon Suk Nam; Yong Soo Park; Jeong Taek Woo; Young Seol Kim; Kyung Mook Choi; Sei Hyun Baik
Journal:  Endocrine       Date:  2013-03-27       Impact factor: 3.633

4.  Perivascular adipose tissue potentiates contraction of coronary vascular smooth muscle: influence of obesity.

Authors:  Meredith Kohr Owen; Frank A Witzmann; Mikaela L McKenney; Xianyin Lai; Zachary C Berwick; Steven P Moberly; Mouhamad Alloosh; Michael Sturek; Johnathan D Tune
Journal:  Circulation       Date:  2013-05-17       Impact factor: 29.690

5.  Visfatin correlates with hot flashes in postmenopausal women with metabolic syndrome: effects of genistein.

Authors:  Alessandra Bitto; Vincenzo Arcoraci; Angela Alibrandi; Rosario D'Anna; Francesco Corrado; Marco Atteritano; Letteria Minutoli; Domenica Altavilla; Francesco Squadrito
Journal:  Endocrine       Date:  2016-04-28       Impact factor: 3.633

Review 6.  Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.

Authors:  Annayya R Aroor; Susan McKarns; Vincent G Demarco; Guanghong Jia; James R Sowers
Journal:  Metabolism       Date:  2013-08-08       Impact factor: 8.694

7.  Inflammatory markers should be assessed together with cardiovascular risk factors by clinicians in masked hypertension.

Authors:  Sevket Balta; Sait Demirkol; Turgay Celik; Murat Unlu; Ugur Kucuk; Zekeriya Arslan
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-29       Impact factor: 3.738

8.  Epoprostenol up-regulates serum adiponectin level in patients with systemic sclerosis: therapeutic implications.

Authors:  Anna Stochmal; Joanna Czuwara; Michał Zaremba; Lidia Rudnicka
Journal:  Arch Dermatol Res       Date:  2021-01-12       Impact factor: 3.017

9.  Adiponectin levels are reduced while markers of systemic inflammation and aortic remodelling are increased in intrauterine growth restricted mother-child couple.

Authors:  Silvia Visentin; Annunziata Lapolla; Ambrogio Pietro Londero; Chiara Cosma; Mariagrazia Dalfrà; Martina Camerin; Diego Faggian; Mario Plebani; Erich Cosmi
Journal:  Biomed Res Int       Date:  2014-06-22       Impact factor: 3.411

10.  Adipocyte nuclei captured from VAT and SAT.

Authors:  Suresh Ambati; Ping Yu; Elizabeth C McKinney; Muthugapatti K Kandasamy; Diane Hartzell; Clifton A Baile; Richard B Meagher
Journal:  BMC Obes       Date:  2016-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.